Announcement on Change of Chief Financial Officer
Filed with SSE · · 2 pages · Chinese
Shanghai Serum Bio-Technology Co., Ltd. on 6ix
Earlier from Shanghai Serum Bio-Technology
- Announcement on Provision for Impairment of Long-term Equity Investment
- Report for Q3 2024
- Announcement on Convening Q3 2024 Performance Briefing
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
- Announcement on Convening 2024 Semi-annual Performance and Cash Dividend Briefing
Later from Shanghai Serum Bio-Technology
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Using Some Temporarily Idle Raised Funds for Cash Management
- Announcement on Changing Project Quality Control Reviewer of Audit Institution
- Announcement on Convening Performance Meeting for 2024 and 1st Quarter of 2025
- Announcement on the Remuneration Plan for Directors, Supervisors and Senior Management Members in 2025
Follow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.
Follow Shanghai Serum Bio-Technology